Company news from the 10/03/06 News Brief

Share this article:
TAP Pharmaceutical Products has agreed to a co-promotion agreement with Novartis Pharmaceuticals Corporation for Famvir (famciclovir), an oral antiviral prescription medication. Under the terms of the agreement, TAP will be responsible for promoting Famvir to the obstetrician/gynecology (OB/GYN) medical community. Financial terms of the agreement were not disclosed.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media